Koh CH - Search Results

1

IL-17 and IL-21: Their Immunobiology and Therapeutic Potentials.

Koh CH, Kim BS, Kang CY, Chung Y, Seo H. Koh CH, et al. Immune Netw. 2024 Jan 19;24(1):e2. doi: 10.4110/in.2024.24.e2. eCollection 2024 Feb. Immune Netw. 2024. PMID: 38455465 Free PMC article. Review.

2

IL-21-mediated reversal of NK cell exhaustion facilitates anti-tumour immunity in MHC class I-deficient tumours.

Seo H, Jeon I, Kim BS, Park M, Bae EA, Song B, Koh CH, Shin KS, Kim IK, Choi K, Oh T, Min J, Min BS, Han YD, Kang SJ, Shin SJ, Chung Y, Kang CY. Seo H, et al. Among authors: koh ch. Nat Commun. 2017 Jun 6;8:15776. doi: 10.1038/ncomms15776. Nat Commun. 2017. PMID: 28585539 Free PMC article.

3

CD8 T-cell subsets: heterogeneity, functions, and therapeutic potential.

Koh CH, Lee S, Kwak M, Kim BS, Chung Y. Koh CH, et al. Exp Mol Med. 2023 Nov;55(11):2287-2299. doi: 10.1038/s12276-023-01105-x. Epub 2023 Nov 1. Exp Mol Med. 2023. PMID: 37907738 Free PMC article. Review.

4

Activation of NKT Cells in an Anti-PD-1-Resistant Tumor Model Enhances Antitumor Immunity by Reinvigorating Exhausted CD8 T Cells.

Bae EA, Seo H, Kim BS, Choi J, Jeon I, Shin KS, Koh CH, Song B, Kim IK, Min BS, Han YD, Shin SJ, Kang CY. Bae EA, et al. Among authors: koh ch. Cancer Res. 2018 Sep 15;78(18):5315-5326. doi: 10.1158/0008-5472.CAN-18-0734. Epub 2018 Jul 16. Cancer Res. 2018. PMID: 30012672

5

GM-CSF Promotes Antitumor Immunity by Inducing Th9 Cell Responses.

Kim IK, Koh CH, Jeon I, Shin KS, Kang TS, Bae EA, Seo H, Ko HJ, Kim BS, Chung Y, Kang CY. Kim IK, et al. Among authors: koh ch. Cancer Immunol Res. 2019 Mar;7(3):498-509. doi: 10.1158/2326-6066.CIR-18-0518. Epub 2019 Feb 6. Cancer Immunol Res. 2019. PMID: 30728152

6

Monocyte-Derived Dendritic Cells Dictate the Memory Differentiation of CD8⁺ T Cells During Acute Infection.

Shin KS, Jeon I, Kim BS, Kim IK, Park YJ, Koh CH, Song B, Lee JM, Lim J, Bae EA, Seo H, Ban YH, Ha SJ, Kang CY. Shin KS, et al. Among authors: koh ch. Front Immunol. 2019 Aug 16;10:1887. doi: 10.3389/fimmu.2019.01887. eCollection 2019. Front Immunol. 2019. PMID: 31474983 Free PMC article.

7

Differentiation of c-Kit⁺ CD24⁺ natural killer cells into myeloid cells in a GATA-2-dependent manner.

Song B, Lee JM, Park YJ, Kim IK, Kim BS, Shin KS, Jeon I, Koh CH, Bae EA, Seo H, Byun Y, Kang CY. Song B, et al. Among authors: koh ch. FASEB J. 2020 Mar;34(3):4462-4481. doi: 10.1096/fj.201902662R. Epub 2020 Jan 27. FASEB J. 2020. PMID: 31989715

8

GITR Agonism Triggers Antitumor Immune Responses through IL21-Expressing Follicular Helper T Cells.

Koh CH, Kim IK, Shin KS, Jeon I, Song B, Lee JM, Bae EA, Seo H, Kang TS, Kim BS, Chung Y, Kang CY. Koh CH, et al. Cancer Immunol Res. 2020 May;8(5):698-709. doi: 10.1158/2326-6066.CIR-19-0748. Epub 2020 Mar 2. Cancer Immunol Res. 2020. PMID: 32122993

9

Enhanced Immunogenicity of Engineered HER2 Antigens Potentiates Antitumor Immune Responses.

Jeon I, Lee JM, Shin KS, Kang T, Park MH, Seo H, Song B, Koh CH, Choi J, Shin YK, Kim BS, Kang CY. Jeon I, et al. Among authors: koh ch. Vaccines (Basel). 2020 Jul 22;8(3):403. doi: 10.3390/vaccines8030403. Vaccines (Basel). 2020. PMID: 32707803 Free PMC article.

10

Type 17 immunity promotes the exhaustion of CD8⁺ T cells in cancer.

Kim BS, Kuen DS, Koh CH, Kim HD, Chang SH, Kim S, Jeon YK, Park YJ, Choi G, Kim J, Kang KW, Kim HY, Kang SJ, Hwang S, Shin EC, Kang CY, Dong C, Chung Y. Kim BS, et al. Among authors: koh ch. J Immunother Cancer. 2021 Jun;9(6):e002603. doi: 10.1136/jitc-2021-002603. J Immunother Cancer. 2021. PMID: 34083422 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

139 results

Search Page